Market Highlights:
The Wolff
Parkinson White Syndrome Market Share is projected to
reach USD 1,659.9 Million by 2030 at 5.2% CAGR during the forecast period
2022-2030.
Wolff-Parkinson-White (WPW)
syndrome is a rare congenital heart disorder involving irregularities in the
electrical transmission system of the heart. In WPW syndrome, an abnormal
alternate electrical pathway exists resulting in arrhythmias (abnormal heartbeat
rhythms) and tachycardia (faster than normal heartbeats). WPW is congenital
but, symptoms may not become apparent until adolescent. Approximately 10 to 20
percent of individuals with WPW syndrome have a congenital heart defect, such
as Ebstein’s anomaly. The disorder’s estimated prevalence is 3 people per 1,000
people in the United States.
The market is driven by
advancements in medical devices such as pacemakers and radiofrequency catheter
ablation. Product development of these devices in terms of miniaturization of
devices and better battery backup is driving the market.
The market drivers for Wolff
Parkinson White syndrome are increasing screening for genetic diseases, rising
awareness, growing income of people etc. The market restraints are the poor
cure rates, poor efficacy and efficiency of effective drugs etc.
Global Wolff Parkinson White
syndrome Market Players
Wolff Parkinson White syndrome market players profiled in the
report are AngioDynamics, Medtronic, Boston Scientific Corporation, St. Jude
Medical, LLC, Abbott, GlaxoSmithKline LLC, Teva Pharmaceutical Industries,
Sanofi S.A., and Novartis International AG and others.
Regional Analysis
The Americas which are dominated by the US account for a
significant market share owing to extensive use of medications and high
expenditure on the health care. Additionally, the fastest uptake of new
instruments and surgical techniques in the US drives the Wolff Parkinson White
syndrome market. The good reimbursement scenario and the greater awareness in
the developed regions drive the market.
Europe is the second largest
market in the world due to high income and healthcare penetration. The European
region is dominated by Germany and France. The presence of large screening
programs in the developed regions drives the market for Wolff Parkinson White
syndrome.
Asia Pacific region is expected
to grow rapidly and China and India are likely to lead this market due to fast
growing healthcare sector during the forecast period.
Gulf nations such as Saudi Arabia
and the UAE are estimated to drive the Middle East & African market. The
African region is expected to witness a moderate growth owing to poor economic
and political conditions and poor healthcare development.
Taste the market data and market
information presented through more than 50 market data tables and figures
spread over 80 pages of the project report. Avail the in-depth table of content
(TOC) & market synopsis on “Global Wolff Parkinson White syndrome Market”
Research Report – Forecast till 2023.
Segmentation
The global Wolff Parkinson White syndrome market outlook has been segmented on the basis of types, diagnosis, treatment and end users.
Based on types, Wolff Parkinson White syndrome has been segmented as type A and type B.
Based on diagnosis, the market has been segmented as Electrocardiogram (ECG), Electrophysiological testing, and others.
Based on treatment, the market has been segmented as drugs, cardioversion, radiofrequency catheter ablation, surgery, artificial pacemaker and others.
Based on the end users, the market has been segmented as hospitals & clinics, academic & research and others.
About US:
Market Research Future (MRFR)
enable customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New
York,
New York 10013
No comments:
Post a Comment